Dedicated Antibody-Drug Conjugates (ADC) Facility
1:16
Dedicated Antibody-Drug Conjugates (ADC) Facility
Күн бұрын
One-stop mRNA Manufacturing, Samsung Biologics
1:15
One-stop mRNA Manufacturing, Samsung Biologics
14 күн бұрын
[Webinar] Formulation Considerations for the Development of High Concentration Biopharmaceuticals
1:00
[Webinar] Formulation Considerations for the Development of High Concentration Biopharmaceuticals
14 күн бұрын
Trusted end-to-end CDMO partner for your journey | OPCU Webinar
0:52
Trusted end-to-end CDMO partner for your journey | OPCU Webinar
3 ай бұрын
Manufacturing concepts for antibody-drug conjugates | Webinar
30:15
Manufacturing concepts for antibody-drug conjugates | Webinar
4 ай бұрын
Harnessing Analytical Development To Empower Process Development For Successful Manufacturing
21:57
Harnessing Analytical Development To Empower Process Development For Successful Manufacturing
4 ай бұрын
Expediting Biologics preclinical development timeline through downstream strategies | Webinar
19:39
Expediting Biologics preclinical development timeline through downstream strategies | Webinar
6 ай бұрын
Navigating challenges during formulation development | Webinar
32:34
Navigating challenges during formulation development | Webinar
6 ай бұрын
Reducing candidate risk with a robust developability assessment tool
21:43
Reducing candidate risk with a robust developability assessment tool
7 ай бұрын
What is LIFE? | Our Story
2:49
What is LIFE? | Our Story
10 ай бұрын
On-Demand Webinar | Enhancing quality by employing cell line replacement and process optimization
27:16
On-Demand Webinar | Enhancing quality by employing cell line replacement and process optimization
10 ай бұрын
BIO PLAZA | Your one-stop place to achieve your well-being
1:20
BIO PLAZA | Your one-stop place to achieve your well-being
10 ай бұрын
Expanding Samsung Biologics’ business into Late Discovery/Early Development
21:56
Expanding Samsung Biologics’ business into Late Discovery/Early Development
11 ай бұрын
What is LIFE?
2:07
What is LIFE?
11 ай бұрын
Optimizing N-glycan Profiles and their effector functions using a design of experiments approach
4:45
Optimizing N-glycan Profiles and their effector functions using a design of experiments approach
Жыл бұрын
S-DUAL™: A novel bispecific antibody scaffold with enhanced heterodimer formation and manufactura..
3:52
S-DUAL™: A novel bispecific antibody scaffold with enhanced heterodimer formation and manufactura..
Жыл бұрын
Driving force of Samsung Biologics’ competitiveness | Leadership Insights (KOR sub)
11:22
Driving force of Samsung Biologics’ competitiveness | Leadership Insights (KOR sub)
Жыл бұрын
[ON DEMAND] Designing an mRNA process development platform: a quality by design approach
17:53
[ON DEMAND] Designing an mRNA process development platform: a quality by design approach
Жыл бұрын
Life Sciences Knowledge Hub | Interview with Senior Vice President Kevin Sharp
7:56
Life Sciences Knowledge Hub | Interview with Senior Vice President Kevin Sharp
Жыл бұрын
DREAM PLANT - Plant 5
1:10
DREAM PLANT - Plant 5
Жыл бұрын
Tackling false-positive endotoxin results in downstream process: A practical approach to β-glucans
22:14
Tackling false-positive endotoxin results in downstream process: A practical approach to β-glucans
Жыл бұрын
Life Sciences Knowledge Hub | Interview with Executive Vice President James Choi
5:35
Life Sciences Knowledge Hub | Interview with Executive Vice President James Choi
Жыл бұрын
Business Review | Partnering with CDMOs for a sustainable future
21:58
Business Review | Partnering with CDMOs for a sustainable future
Жыл бұрын
The Future of Biopharma: Plant 4
2:34
The Future of Biopharma: Plant 4
Жыл бұрын
Counting Medicines’ Carbon Emissions
2:30
Counting Medicines’ Carbon Emissions
Жыл бұрын
Contract Pharma | New Approaches in Bispecific Antibody Development
22:11
Contract Pharma | New Approaches in Bispecific Antibody Development
Жыл бұрын
Accelerating Excellence
0:54
Accelerating Excellence
Жыл бұрын
Committed to mRNA Innovators
5:04
Committed to mRNA Innovators
Жыл бұрын
PharmTech | Key Considerations When Selecting a mRNA CDMO Partner
28:43
PharmTech | Key Considerations When Selecting a mRNA CDMO Partner
Жыл бұрын
Пікірлер